Table 2.

Microbiological results and univariate analysis comparing patients with acute lower respiratory infections (ALRI) on pulmonary sequelae (ALRIPS) (reference group), with ALRI on previously healthy lungs (ALRIHL), and with active pulmonary tuberculosis (TB), SISEA study, Cambodia, 2007–2010.

Pathogens	ALRIPS	ALRIHL	p	TB	p
	n (%)	n (%)		n (%)
Bacterial cultures of at least one sputum or blood sample	n = 414	n = 829		n = 478
H. influenzae	53 (12.8)	45 (5.4)	<0.001	21 (4.4)	<0.001
S. pneumoniae	23 (5.6)	26 (3.1)	0.039	10 (2.1)	0.006
P. aeruginosa	15 (3.6)	15 (1.8)	0.05	5 (1.0)	0.01
K. pneumoniae	12 (2.9)	29 (3.5)	0.57	5 (1.0)	0.044
S. aureus	5 (1.2)	3 (0.4)	0.087	3 (0.6)	0.28
B. pseudomallei	1 (0.2)	30 (3.6)	<0.001	1 (0.2)	0.91
Other Gram negative bacilli	8 (1.9)a	16 (1.9)b	0.99	3 (0.6)c	0.078
Dual bacterial infection	10 (2.4)	15 (1.8)	0.47	3 (0.6)	0.02
Viral RT-PCR	n = 417	n = 853		n = 483
Rhinovirus	20 (4.8)	40 (4.7)	0.93	19 (3.9)	0.52
Influenza A or B	8 (1.9)	9 (1.0)	0.20	3 (0.6)	0.07
Respiratory syncytial virus	9 (2.1)	15 (1.8)	0.62	8 (1.7)	0.58
Coronavirus	10 (2.4)	16 (1.9)	0.53	1 (0.2)	0.003
Other viruses	5 (1)d	13 (2)e	0.65	3 (1)f	0.35
Dual viral infection	2	2	0.46	0	NA

NA: not applicable. Significant values are in bold (p < 0.05).

^aA. baumannii (n = 5), E. coli (n = 2), S. marcescens (n = 1).

^bA. baumannii (n = 6), E. coli (n = 9), R. pickettii (n = 1).

^cA. baumannii (n = 1), E. coli (n = 1), P. mirabilis (n = 1).

^dParainfluenzae virus (n = 3), adenovirus (n = 1), human metapneumovirus (n = 1).

^eParainfluenzae virus (n = 3), adenovirus (n = 2), human metapneumovirus (n = 7), bocavirus (n = 1).

^fParainfluenzae virus (n = 1), adenovirus (n = 2).